carnosine has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, Y; Kurabayashi, T; Nishijima, S; Tamura, M; Tamura, R; Tsuneki, I; Yanase, T | 1 |
| Książek, K; Mikuła-Pietrasik, J | 1 |
2 other study(ies) available for carnosine and Cancer of Ovary
| Article | Year |
|---|---|
[Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carnosine; Female; Humans; Neoplasm Staging; Organometallic Compounds; Ovarian Neoplasms; Paclitaxel; Taste Disorders; Zinc Compounds | 2011 |
L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Carnosine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cellular Senescence; Dose-Response Relationship, Drug; Female; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Time Factors | 2016 |